GAD1 and ovarian neoplasm: To conclude, our research demonstrated that the combined treatment of GAD and cisplatin increases the intracellular level of ROS, inhibits ERK phosphorylation activation, and subsequently suppresses cell proliferation and promotes cell death in the ovarian tumor.